Author

Salvador García-Carmona

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Tofacitinib Reduces KL-6 Levels in Patients With Rheumatoid Arthritis-Associated Interstitial Lung Disease. Results Of A Phase II Investigator-Initiated Study.

This trial estimates the rates of adverse events, mortality, low disease activity, PPF, decline in FVC in RA-ILD, and decline in serum KL-6 in patients treated with tofacitinib NCT05246293.

J. Rojas-Serrano, E. Ramos-Martínez, M. Mejía et al. · Respiratory Medicine · 1 citation